We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
People who get cochlear implants to treat severe hearing loss may develop new bone growth in the ear — and it may lessen any hearing they have left, a new study hints.
The U.S. Court of Appeals for the Federal Circuit has affirmed a $268 million award in favor of the Alfred E. Mann Foundation for Scientific Research (AMF) in a long-running dispute with Australia-based Cochlear Corporation over ground-breaking cochlear i
Sensorion and Cochlear will evaluate SENS-401 in combination with Cochlear’s cochlear implants in preclinical setting in 2018, with potential mid-stage clinical testing to begin as soon as 2019
China is already among Cochlear’s top five international markets and is its fastest growing market by volume, with potential to deliver more strong growth over the next decade.